๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update.

โœ Scribed by Giardine, Belinda (author);van Baal, Sjozef (author);Kaimakis, Polynikis (author);Riemer, Cathy (author);Miller, Webb (author);Samara, Maria (author);Kollia, Panagoula (author);Anagnou, Nicholas P. (author);Chui, David H.K. (author);Wajcman, Henri (author);Hardison, Ross C. (author);Patrinos, George P. (author)


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
268 KB
Volume
28
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


HbVar database of human hemoglobin varia
โœ Giardine, Belinda (author);van Baal, Sjozef (author);Kaimakis, Polynikis (author ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 268 KB

HbVar (http://globin.bx.psu.edu/hbvar) is a locus-specific database (LSDB) developed in 2001 by a multi-center academic effort to provide timely information on the genomic sequence changes leading to hemoglobin variants and all types of thalassemia and hemoglobinopathies. Database records include ex

HbVar: A relational database of human he
โœ Hardison, Ross C. (author);Chui, David H.K. (author);Giardine, Belinda (author); ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 341 KB

We have constructed a relational database of hemoglobin variants and thalassemia mutations, called HbVar, which can be accessed on the web at http://globin.cse.psu.edu. Extensive information is recorded for each variant and mutation, including a description of the variant and associated pathology, h

Update of the Pompe disease mutation dat
โœ Marian Kroos; Robert J. Pomponio; Laura van Vliet; Rachel E. Palmer; Michael Phi ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 206 KB

Communicated by Elizabeth F. Neufeld Pompe disease was named after the Dutch pathologist Dr JC Pompe who reported about a deceased infant with idiopathic hypertrophy of the heart. The clinical findings were failure to thrive, generalized muscle weakness and cardio-respiratory failure. The key pathol